Percocet

Endo is a specialty pharmaceutical company that develops, manufactures, and distributes a wide range of branded and generic pharmaceutical products. The company is most notably associated with its pain management portfolio, which includes the well-known brand Percocet, a combination of oxycodone and acetaminophen. Beyond analgesics, Endo has a significant presence in medical aesthetics and orthopedics, driven by its lead biologic product, XIAFLEX. In 2024, the company successfully emerged from a Chapter 11 financial restructuring as Endo, Inc., having addressed legacy opioid-related legal liabilities. Today, the company operates through segments focused on Branded Specialties, Sterile Injectables, and Generic medicines. Endo maintains a global footprint with headquarters in Dublin, Ireland, and primary operations in Malvern, Pennsylvania.